News

Study Design: Conducted as an open, single-center clinical trial, the study involved 25 women aged 18-50 who exhibited common symptoms of brittle nails. This trial followed a daily intake of 2.5g of VERISOL® over a duration of 6 months. Additionally, a four-week observation period followed the intervention to assess any sustained effects. 

Key Findings: The results of the study shed light on the positive implications of VERISOL® on fingernails. 

• 75% Participants experienced improvements in the quality and growth of their nails, addressing the common issue of brittleness. 

• The trial demonstrated the potential of VERISOL® to contribute to overall nail health, a critical factor in the broader spectrum of collagen-related benefits. 

Conclusion: Clinical Study IV, conducted as an open, single-center trial over a 6-month period, reveals encouraging findings regarding the positive effects of VERISOL® on the quality and growth of fingernails. This study adds to the growing body of evidence supporting the multifaceted benefits of VERISOL® in promoting overall health and well-being.

Study Introduction:  The study V focused on unraveling the effectiveness of VERISOL® on the structure and metabolism of hair, recognizing the crucial role of collagen in contributing to overall hair health. The study aimed to provide valuable insights into how VERISOL® influences key aspects of hair structure and appearance. 

Study Design: Conducted as a randomized, placebo-controlled study, the research included 44 healthy women aged between 39 and 75. The participants were randomly assigned to either a daily intake of 2.5g of VERISOL® or a placebo over a comprehensive 16-week duration. This design aimed to assess the sustained effects of VERISOL® on hair health. 

Key Findings:

• The results presented significant improvements in hair thickness, a critical indicator of enhanced hair structure and appearance. 
• The increased thickness translated into improved textural and physical properties of the hair, rendering it stronger and more resistant to breakage. 
• Moreover, a cell culture experiment conducted as part of the study revealed a noteworthy 31% increase in the proliferation rate of human hair follicle cells. 

This finding strongly suggested a positive effect of VERISOL® on hair metabolism, underscoring its potential in promoting optimal hair health. 

Conclusion: The study structured as a randomized, placebo-controlled investigation over 16 weeks, substantiates the positive impact of VERISOL® on hair structure and metabolism. These findings contribute to the growing body of evidence supporting the diverse benefits of VERISOL® in fostering overall hair health.

Study Introduction: This clinical investigation was meticulously designed to explore the efficacy of VERISOL® in the treatment of cellulite, addressing a common concern among women. The study focused on assessing VERISOL®'s ability to combat cellulite in both normal-weight and overweight women, providing valuable insights into its potential applications. 

Study Design: Employing a rigorous double-blind, placebo-controlled trial, the study enrolled 105 women aged 24-50. The participants were divided into two subgroups based on BMI—those with BMI < 25 and those with BMI > 25. Each subgroup was subjected to a daily intake of 2.5g VERISOL® or a placebo. The duration of the trial extended over a significant period of 6 months. 

Key Findings

• The results revealed promising outcomes in the reduction of cellulite-related indicators.

• Across the overall VERISOL® group, there was a significant decrease in skin waviness, registering an impressive -8% reduction. 

• Moreover, the subgroup of women with normal weight (BMI < 25) experienced an even more notable improvement, with an -11% reduction in skin waviness. 

• Notably, the study also identified a significantly higher dermal density after 6 months in the VERISOL® group compared to the placebo, highlighting the comprehensive benefits of VERISOL® in treating cellulite. 

Conclusion: This comprehensive study, conducted over a 6-month duration, underscores VERISOL®’s potential as an effective treatment for cellulite, offering encouraging results in both normal-weight and overweight women.

Study Introduction: This clinical study delved into assessing the effectiveness of VERISOL® in reducing wrinkles—a vital parameter in gauging the efficacy of collagen peptides in addressing signs of aging. The focus was on understanding the impact of VERISOL® on wrinkle reduction among women aged 45-65.

Study Design: Similar to the first clinical study, this investigation adopted a double-blind, placebo-controlled trial design. A total of 114 women participated in the study, with each group assigned to either a daily intake of 2.5g VERISOL® or a placebo. The trial spanned 8 weeks, with measurements taken at pivotal intervals—4 and 8 weeks into the study, followed by a 4-week washout period.

 Key Findings: 

• The outcomes were compelling, showcasing a significant reduction in wrinkle volume among those who consumed 2.5g of VERISOL® compared to the placebo group.
• Furthermore, the study identified a substantial increase in the concentration of pro-collagen, emphasizing the positive impact of VERISOL® on collagen synthesis.
• Additionally, a significant increase in skin elastin was observed, further affirming the comprehensive benefits of VERISOL® in promoting skin health.

Conclusion: This study, a valuable contribution to the understanding of collagen peptide efficacy, reinforces VERISOL®'s role in reducing wrinkles and enhancing key components of skin structure.

Study Introduction: Conducted as a double-blind, placebo-controlled trial, the research aimed to assess the effectiveness of VERISOL® collagen peptides in addressing key biophysical skin parameters associated with cutaneous aging. The study enlisted over 60 women aged 35-55, all with normal skin characteristics. 

Study Design: Participants were divided into two groups—one receiving a daily intake of 2.5g VERISOL® collagen peptides and the other a placebo. The trial spanned 8 weeks, with measurements taken at crucial intervals—4 and 8 weeks into the study. Additionally, a 4-week washout period followed the completion of the trial. 

Key Findings:

• The results revealed a noteworthy outcome in terms of skin elasticity. 
• Those who consumed 2.5g of VERISOL® exhibited a substantial increase in skin elasticity compared to the placebo group at both the 4-week and 8-week intervals. 
• Importantly, this positive impact on skin elasticity endured even during the subsequent 4-week washout phase, suggesting a sustained and enduring dermal physiological effect. 

Conclusion: The study, authored by Proksch et al in 2014 and published in Skin Pharmacol Physiol (27:47-55), provides compelling evidence for the beneficial effects of specific collagen peptides, particularly VERISOL®, on enhancing human skin physiology.